Replies to post #73369 on Bioelectronics Corp (BIEL)

[Simpsonly]

I know I never trust redactions; they manipulate and distort the truth.
Also, if, as and when the company decides it is in the best interests of itself, to protect its business enterprise, and its shareholders, to issue a press release confirming its status with respect to its 510(k) application to the FDA for OTC Clearance for the sale of ActiPatch here in the U.S., it will do so. Until then it is blatantly remaining silent, as it should and as it must! Security laws require that!

[JustGoDeep]

Recommend-shorting-it-because-"I-love-the-smell-of-Napalm-in-the-morning."

[Steve43]

Constitutes improper professional business conduct. I don't see the word fraud just improper business conduct. All to be determined, I see no guilty decision here do you ? They have months of preparation and back and forth yet to come. So "I" trust what ever the outcome is pertaining to the "REDACTED" as a rational investor should I assume nothing. Have a great day. As far as ddls comment BIEL "Is an ongoing concern and financials will be stated" Have a wonderful day.

[rodman]

First the company cannot disclose the FDA status because they DO NOT know it. You summize there is guilt on the company's part in all facets including the CPA- Auditor and is baseless. After Madhoff accoutant's do not issue publicly issued financial statement as midleading that is criminal. SEC is a bureacracy given over board police power IMO! Ultimately this case will be closed with no further action!